Clinical Trial Update: ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized open-label trial evaluating a switch strategy for cholesterol elevation in patients on Kivexa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kivexa (abacavir/lamivudine)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED